Ahead Therapeutics has closed an agreement with Dr. med. Ribes-Koninck from La Fe Hospital & Research institute to perform ex-vivo assays with CD patients’ samples.

Ahead Therapeutics will verify the platform potential of its PS-Liposomes with blood samples coming from Celiac Disease’s patients. Researchers from the group of Dr. Ribes-Konickx (Head of the Paediatric Gastrohepatology unit and coordinator of the Special Celiac Disease Interest Group from ESPGHAN) will carry out patients’ recruitment and the experimental processing of the samples.